BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 16894289)

  • 1. Treatment of early-stage nonbulky Hodgkin lymphoma.
    Straus DJ
    Curr Opin Oncol; 2006 Sep; 18(5):432-6. PubMed ID: 16894289
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The case for chemotherapy only for localized Hodgkin lymphoma.
    Straus DJ
    Oncologist; 2009 Dec; 14(12):1225-31. PubMed ID: 20007643
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Prognosis and treatment strategies of primary B-cell and NK/T-cell nasopharyngeal non-Hodgkin's lymphoma at early stage].
    Zou GR; Zhang YJ; Xie FY; Zheng W; Li HX; Xia YF; Lin TY; Lu TX
    Ai Zheng; 2006 Dec; 25(12):1543-9. PubMed ID: 17166383
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term events in adult patients with clinical stage IA-IIA nonbulky Hodgkin's lymphoma treated with four cycles of doxorubicin, bleomycin, vinblastine, and dacarbazine and adjuvant radiotherapy: a single-institution 15-year follow-up.
    Brusamolino E; Baio A; Orlandi E; Arcaini L; Passamonti F; Griva V; Casagrande W; Pascutto C; Franchini P; Lazzarino M
    Clin Cancer Res; 2006 Nov; 12(21):6487-93. PubMed ID: 17085663
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcome of patients experiencing progression or relapse after primary treatment with two cycles of chemotherapy and radiotherapy for early-stage favorable Hodgkin's lymphoma.
    Sieniawski M; Franklin J; Nogova L; Glossmann JP; Schober T; Nisters-Backes H; Diehl V; Josting A
    J Clin Oncol; 2007 May; 25(15):2000-5. PubMed ID: 17420510
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined chemoradiation for the management of nasal natural killer (NK)/T-cell lymphoma: elucidating the significance of systemic chemotherapy.
    Guo Y; Lu JJ; Ma X; Wang B; Hong X; Li X; Li J
    Oral Oncol; 2008 Jan; 44(1):23-30. PubMed ID: 17306611
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiotherapy for early-stage Hodgkin's lymphoma: a 21st century perspective and review of multiple randomized clinical trials.
    Bar Ad V; Paltiel O; Glatstein E
    Int J Radiat Oncol Biol Phys; 2008 Dec; 72(5):1472-9. PubMed ID: 19028275
    [TBL] [Abstract][Full Text] [Related]  

  • 8. First-line treatment of Hodgkin's lymphoma.
    Klimm B; Engert A; Diehl V
    Curr Hematol Rep; 2005 Jan; 4(1):15-22. PubMed ID: 15610655
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ACR Appropriateness Criteria on Hodgkin's lymphoma: favorable prognosis stage I and II.
    Das P; Ng A; Constine LS; Hodgson DC; Mendenhall NP; Morris DE; Yunes MJ; Chauvenet AR; Hudson MM; Winter JN
    J Am Coll Radiol; 2008 Oct; 5(10):1054-66. PubMed ID: 18812149
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Twenty-year disease and treatment-associated mortality rates of patients with Hodgkin lymphoma of clinical stages IIIB and IV prospectively treated with 3-month anthracycline-based chemotherapy followed by extended high-dose radiation.
    Sénécal D; Jais JP; Desablens B; Berthou C; Casassus P; Moles MP; Delwail V; Gastinne T; Colonna P; Andrieu JM
    Cancer; 2008 Feb; 112(4):846-55. PubMed ID: 18072259
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of positive positron emission tomography on prediction of freedom from progression after Stanford V chemotherapy in Hodgkin's disease.
    Advani R; Maeda L; Lavori P; Quon A; Hoppe R; Breslin S; Rosenberg SA; Horning SJ
    J Clin Oncol; 2007 Sep; 25(25):3902-7. PubMed ID: 17664458
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Treatment results of stage IA Hodgkin lymphoma: a report of 97 cases].
    Tan WY; Hu DS; Zeng FY; Song QB; Hu S; Wei L; Zhou LQ
    Ai Zheng; 2007 Dec; 26(12):1360-4. PubMed ID: 18076802
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of radiation therapy in Hodgkin's lymphoma.
    Yahalom J
    Cancer J; 2009; 15(2):155-60. PubMed ID: 19390312
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase III multi-institutional trial of adjuvant chemotherapy with paclitaxel, estramustine, and oral etoposide combined with long-term androgen suppression therapy and radiotherapy versus long-term androgen suppression plus radiotherapy alone for high-risk prostate cancer: preliminary toxicity analysis of RTOG 99-02.
    Rosenthal SA; Bae K; Pienta KJ; Sobczak ML; Asbell SO; Rajan R; Kerlin KJ; Michalski JM; Sandler HM;
    Int J Radiat Oncol Biol Phys; 2009 Mar; 73(3):672-8. PubMed ID: 18990504
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined modality treatment of Hodgkin's lymphoma.
    Klimm B; Engert A
    Cancer J; 2009; 15(2):143-9. PubMed ID: 19390310
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Radiotherapy treatment of lymphoma].
    Juretić A; Zivković M; Samija M; Cović D; Bistrović M; Viculin T; Bagović D; Tomek R
    Lijec Vjesn; 2000; 122(11-12):283-91. PubMed ID: 11291272
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of pediatric Hodgkin's lymphoma.
    Hudson MM; Donaldson SS
    Semin Hematol; 1999 Jul; 36(3):313-23. PubMed ID: 10462331
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modern treatment of Hodgkin lymphoma.
    Bartlett NL
    Curr Opin Hematol; 2008 Jul; 15(4):408-14. PubMed ID: 18536581
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [CEOP regimen in the treatment for non-Hodgkin's lymphoma].
    Huang HQ; Lin XB; Pan ZH; Bu Q; Gao Y; Wang BF; Cai QQ; Xia ZJ; Xu RH; Jiang WQ; Guan ZZ
    Zhonghua Zhong Liu Za Zhi; 2007 May; 29(5):391-5. PubMed ID: 17892140
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advances in the management of HIV-related non-Hodgkin lymphoma.
    Behler CM; Kaplan LD
    Curr Opin Oncol; 2006 Sep; 18(5):437-43. PubMed ID: 16894290
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.